236 related articles for article (PubMed ID: 18465053)
1. Renal tubular function in patients with beta-thalassaemia major in Zahedan, southeast Iran.
Sadeghi-Bojd S; Hashemi M; Karimi M
Singapore Med J; 2008 May; 49(5):410-2. PubMed ID: 18465053
[TBL] [Abstract][Full Text] [Related]
2. Kidney function tests in children with beta-thalassemia minor in Zahedan, southeast of Iran.
Sadeghi-Bojd S; Hashemi M; Naderi M; Shikhani S
Iran J Kidney Dis; 2011 Jul; 5(3):201-3. PubMed ID: 21525581
[TBL] [Abstract][Full Text] [Related]
3. Renal complications in transfusion-dependent beta thalassaemia.
Ponticelli C; Musallam KM; Cianciulli P; Cappellini MD
Blood Rev; 2010 Nov; 24(6):239-44. PubMed ID: 20850917
[TBL] [Abstract][Full Text] [Related]
4. Renal tubular dysfunction in pediatric patients with beta-thalassemia major.
Ahmadzadeh A; Jalali A; Assar S; Khalilian H; Zandian K; Pedram M
Saudi J Kidney Dis Transpl; 2011 May; 22(3):497-500. PubMed ID: 21566307
[TBL] [Abstract][Full Text] [Related]
5. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of QT dispersion in beta thalassaemia major patients.
Ulger Z; Aydinok Y; Levent E; Gurses D; Ozyurek AR
Am J Hematol; 2006 Dec; 81(12):901-6. PubMed ID: 16924653
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
De Sanctis V; Eleftheriou A; Malaventura C;
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of beta thalassaemia.
Origa R; Galanello R
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():263-70. PubMed ID: 21705976
[TBL] [Abstract][Full Text] [Related]
9. Plasma chitotriosidase activity in patients with beta-thalassemia.
Barone R; Di Gregorio F; Romeo MA; Schilirò G; Pavone L
Blood Cells Mol Dis; 1999 Feb; 25(1):1-8. PubMed ID: 10349508
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
[TBL] [Abstract][Full Text] [Related]
11. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
12. Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia.
Deveci B; Kurtoglu A; Kurtoglu E; Salim O; Toptas T
Ann Hematol; 2016 Feb; 95(3):375-81. PubMed ID: 26596972
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant micronutrients in children with thalassaemia in Egypt.
Nasr MR; Ali S; Shaker M; Elgabry E
East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
Karamifar H; Shahriari M; Sadjadian N
East Mediterr Health J; 2003; 9(1-2):55-60. PubMed ID: 15562733
[TBL] [Abstract][Full Text] [Related]
16. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
17. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
[TBL] [Abstract][Full Text] [Related]
18. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
Gamberini MR; De Sanctis V; Gilli G
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy.
Filosa A; Valgimigli L; Pedulli GF; Sapone A; Maggio A; Renda D; Scazzone C; Malizia R; Pitrolo L; Lo Pinto C; Borsellino Z; Cuccia L; Capra M; Canistro D; Broccoli M; Soleti A; Paolini M
Br J Haematol; 2005 Oct; 131(1):135-40. PubMed ID: 16173974
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of renal findings in Beta-thalassemia major and intermedia.
Ali D; Mehran K; Moghaddam AG
Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):206-9. PubMed ID: 18310868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
